Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

BUY
$110.08 - $142.92 $3.17 Million - $4.12 Million
28,800 Added 126.87%
51,500 $6.11 Million
Q4 2021

Feb 15, 2022

BUY
$99.73 - $148.48 $1.84 Million - $2.73 Million
18,400 Added 427.91%
22,700 $3.13 Million
Q3 2021

Nov 16, 2021

SELL
$98.85 - $138.91 $7.94 Million - $11.2 Million
-80,300 Reduced 94.92%
4,300 $597,000
Q4 2020

Feb 17, 2021

BUY
$65.07 - $98.24 $5.23 Million - $7.9 Million
80,400 Added 1914.29%
84,600 $7.25 Million
Q3 2020

Nov 17, 2020

SELL
$59.04 - $77.95 $572,688 - $756,115
-9,700 Reduced 69.78%
4,200 $273,000
Q2 2020

Aug 17, 2020

BUY
$29.01 - $74.23 $269,793 - $690,339
9,300 Added 202.17%
13,900 $1.02 Million
Q4 2019

Feb 14, 2020

BUY
$40.86 - $57.65 $187,956 - $265,190
4,600 New
4,600 $250,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.